Publication date: Mar 24, 2025
According to data from the National Disease Control and Prevention Administration, the incidence and mortality rates of TB in China have fallen by 30 percent since 2012. In March, Jiangsu’s capital city of Nanjing launched one of the country’s first zero-cost treatment plans for drug-resistant TB using BPaL — the latest short-course regimen worldwide. Beyond financial and policy support, China is also committed to innovation, aiming to further enhance TB prevention and treatment. The first patient to receive the regimen in Nanjing said, “I was under immense pressure, worrying about whether the disease could be cured. Hu Linjia, a university student volunteer, has been visiting local communities and using interactive quizzes to educate the elderly on TB prevention and control. Jointly issued by nine authorities, the plan integrates responsibilities across 15 government departments into an accountability framework, strengthening interagency coordination to ensure policy implementation. “AI can quickly flag lung abnormalities, allowing faster diagnosis at the grassroots level,” said Tang Qingyan, a doctor with a local hospital.
| Concepts | Keywords |
|---|---|
| Eradicating | China |
| Global | Control |
| Tuberculosisbeijing | Efforts |
| Volunteer | Jiangsu |
| Local | |
| Mortality | |
| Percent | |
| Prevention | |
| Province | |
| Rate | |
| Rates | |
| Said | |
| Tb | |
| Treatment | |
| Tuberculosis |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Bedaquiline |
| disease | MESH | abnormalities |
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | IDO | country |
| drug | DRUGBANK | Spinosad |
| drug | DRUGBANK | Pretomanid |
| drug | DRUGBANK | Linezolid |